Amita Gupta1, Jyoti S Mathad2, Wei-Teng Yang3, Harjot K Singh2, Nikhil Gupte4, Vidya Mave4, Renu Bharadwaj5, K Zaman6, Eliza Roy6, Robert C Bollinger7, Ramesh Bhosale5, Mark C Steinhoff8. 1. Johns Hopkins University School of Medicine, Baltimore, MD, United States; Bloomberg School of Public Health, Baltimore, MD, United States; Johns Hopkins University, Byramjee Jeejeebhoy Government Medical College HIV Clinical Trials Unit, Pune, India. Electronic address: agupta25@jhmi.edu. 2. Weill Cornell Medical College, New York, NY, United States. 3. Johns Hopkins University School of Medicine, Baltimore, MD, United States. 4. Johns Hopkins University School of Medicine, Baltimore, MD, United States; Johns Hopkins University, Byramjee Jeejeebhoy Government Medical College HIV Clinical Trials Unit, Pune, India. 5. Johns Hopkins University, Byramjee Jeejeebhoy Government Medical College HIV Clinical Trials Unit, Pune, India; Byramjee Jeejeebhoy Government Medical College, Sassoon General Hospital, Pune, India. 6. International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh. 7. Johns Hopkins University School of Medicine, Baltimore, MD, United States; Bloomberg School of Public Health, Baltimore, MD, United States; Johns Hopkins University, Byramjee Jeejeebhoy Government Medical College HIV Clinical Trials Unit, Pune, India. 8. Cincinnati Children's Hospital, Cincinnati, OH, United States.
Abstract
BACKGROUND: Our understanding of the mother-to-child transfer of serotype-specific pneumococcal antibodies is limited in non-immunized, HIV-positive women. METHODS: We compared geometric mean antibody concentrations (GMCs), geometric mean transplacental cord:maternal ratios (GMRs) and proportions of samples with protective antibody concentration (≥0.35μg/ml) to serotypes 1, 4, 5, 6B, 9V, 14, 18C, 19F, 23F between 74 HIV-infected and 98 HIV-uninfected mother-infant pairs who had not received pneumococcal immunization in South Asia. Multivariable analysis was performed to assess the influence of HIV on protective antibody concentrations. RESULTS: HIV-infected mothers and their infants exhibited lower GMCs and GMRs than their uninfected counterparts. This was significant for all serotypes except maternal GMC to serotype 1 and GMR for serotype 6B. In multivariate analysis, HIV was significantly associated with reduced odds of having protective pneumococcal IgG levels; 56-73% reduction for 3 maternal serotypes (4, 5, 23F) and 62-90% reduction for all cord samples except serotype 6B. CONCLUSIONS: Maternal HIV infection is associated with lower levels of maternal pneumococcal antibodies and disproportionately lower cord antibodies, relative to maternal antibodies, suggesting that HIV infection compromises transplacental transfer. Reassessment of maternal and/or infant pneumococcal immunization strategies is needed in HIV-infected women and their infants.
BACKGROUND: Our understanding of the mother-to-child transfer of serotype-specific pneumococcal antibodies is limited in non-immunized, HIV-positive women. METHODS: We compared geometric mean antibody concentrations (GMCs), geometric mean transplacental cord:maternal ratios (GMRs) and proportions of samples with protective antibody concentration (≥0.35μg/ml) to serotypes 1, 4, 5, 6B, 9V, 14, 18C, 19F, 23F between 74 HIV-infected and 98 HIV-uninfected mother-infant pairs who had not received pneumococcal immunization in South Asia. Multivariable analysis was performed to assess the influence of HIV on protective antibody concentrations. RESULTS:HIV-infected mothers and their infants exhibited lower GMCs and GMRs than their uninfected counterparts. This was significant for all serotypes except maternal GMC to serotype 1 and GMR for serotype 6B. In multivariate analysis, HIV was significantly associated with reduced odds of having protective pneumococcal IgG levels; 56-73% reduction for 3 maternal serotypes (4, 5, 23F) and 62-90% reduction for all cord samples except serotype 6B. CONCLUSIONS:Maternal HIV infection is associated with lower levels of maternal pneumococcal antibodies and disproportionately lower cord antibodies, relative to maternal antibodies, suggesting that HIV infection compromises transplacental transfer. Reassessment of maternal and/or infantpneumococcal immunization strategies is needed in HIV-infectedwomen and their infants.
Authors: W Abdullah Brooks; Robert F Breiman; Doli Goswami; Anowar Hossain; Khorshed Alam; Samir K Saha; Kamrun Nahar; Dilruba Nasrin; Noor Ahmed; Shams El Arifeen; Aliya Naheed; David A Sack; Stephen Luby Journal: Am J Trop Med Hyg Date: 2007-11 Impact factor: 2.345
Authors: K Zaman; Eliza Roy; Shams E Arifeen; Mahbubur Rahman; Rubhana Raqib; Emily Wilson; Saad B Omer; Nigar S Shahid; Robert F Breiman; Robert E Breiman; Mark C Steinhoff Journal: N Engl J Med Date: 2008-09-17 Impact factor: 91.245
Authors: Sandra J Bliss; Katherine L O'Brien; Edward N Janoff; Mark F Cotton; Philippa Musoke; Hoosen Coovadia; Orin S Levine Journal: Lancet Infect Dis Date: 2007-10-31 Impact factor: 25.071
Authors: Katherine L O'Brien; Jennifer Moisi; Lawrence H Moulton; Dace Madore; Angelia Eick; Ray Reid; Robert Weatherholtz; Eugene Millar; Diana Hu; Jill Hackell; Robert Kohberger; George Siber; Mathuram Santosham Journal: J Infect Dis Date: 2007-05-24 Impact factor: 5.226
Authors: Shams E Arifeen; Samir K Saha; Sayedur Rahman; Kazi Mizanur Rahman; Syed Moshfiqur Rahman; Sanwarul Bari; Aliya Naheed; Ishtiaq Mannan; M Habibur R Seraji; Nawshad U Ahmed; M Shameem Hassan; Nazmul Huda; Ashraf Uddin Siddik; Iftekhar Quasem; Maksuda Islam; Kaniz Fatima; Hassan Al-Emran; W Abdullah Brooks; Abdullah H Baqui; Robert F Breiman; David Sack; Stephen P Luby Journal: Clin Infect Dis Date: 2009-03-01 Impact factor: 9.079
Authors: Samir K Saha; Aliya Naheed; Shams El Arifeen; Maksuda Islam; Hassan Al-Emran; Ruhul Amin; Kaniz Fatima; W Abdullah Brooks; Robert F Breiman; David A Sack; Stephen P Luby Journal: Clin Infect Dis Date: 2009-03-01 Impact factor: 9.079
Authors: David R Martinez; Youyi Fong; Shuk Hang Li; Fang Yang; Madeleine F Jennewein; Joshua A Weiner; Erin A Harrell; Jesse F Mangold; Ria Goswami; George R Seage; Galit Alter; Margaret E Ackerman; Xinxia Peng; Genevieve G Fouda; Sallie R Permar Journal: Cell Date: 2019-06-13 Impact factor: 41.582
Authors: James T Gaensbauer; Jeremy T Rakhola; Carolyne Onyango-Makumbi; Michael Mubiru; Jamie E Westcott; Nancy F Krebs; Edwin J Asturias; Mary Glenn Fowler; Elizabeth McFarland; Edward N Janoff Journal: Clin Vaccine Immunol Date: 2014-10-08
Authors: Jessica E Atwell; Bhagvanji Thumar; Leanne J Robinson; Roselyn Tobby; Phantica Yambo; Maria Ome-Kaius; Peter M Siba; Holger W Unger; Stephen J Rogerson; Christopher L King; Ruth A Karron Journal: J Infect Dis Date: 2015-08-03 Impact factor: 5.226
Authors: Sarah M Labuda; Yanling Huo; Deborah Kacanek; Kunjal Patel; Krista Huybrechts; Jennifer Jao; Christiana Smith; Sonia Hernandez-Diaz; Gwendolyn Scott; Sandra Burchett; Fatima Kakkar; Ellen G Chadwick; Russell B Van Dyke Journal: Clin Infect Dis Date: 2020-07-11 Impact factor: 9.079
Authors: Kirsty Le Doare; Lauren Allen; Beate Kampmann; Paul Trafford Heath; Stephen Taylor; Anneke C Hesseling; Andrew Gorringe; Christine Elizabeth Jones Journal: Vaccine Date: 2014-12-24 Impact factor: 3.641
Authors: Ellen Heinsbroek; Terence Tafatatha; Christina Chisambo; Amos Phiri; Oddie Mwiba; Bagrey Ngwira; Amelia C Crampin; Jonathan M Read; Neil French Journal: Am J Epidemiol Date: 2015-12-01 Impact factor: 4.897
Authors: Anna Babakhanyan; Gabriel Loni Ekali; Arlene Dent; James Kazura; John Tamo Nguasong; Barriere Airy Yetgang Fodjo; Emile Keming Yuosembom; Livo Forgu Esemu; Diane Wallace Taylor; Rose Gana Fomban Leke Journal: Open Forum Infect Dis Date: 2016-05-10 Impact factor: 3.835